Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of botulinum toxin in obese patients
IRCT20230408057842N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox in obesity and Overweight, sponsored by Shahid Beheshti University of Medical Sciences. Started Nov 2023; status: completed.
02
Drugs
neuronox
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on IRCT20230408057842N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230408057842N2.